BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 27072094)

  • 21. Clinical EEG in cognitively impaired patients with Parkinson's Disease.
    Schlede N; Zimmermann R; Ehrensperger MM; Gschwandtner U; Hardmeier M; Hatz F; Monsch AU; Naegelin Y; Fuhr P
    J Neurol Sci; 2011 Nov; 310(1-2):75-8. PubMed ID: 21705023
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mild cognitive impairment in Parkinson's disease and its progression onto dementia: a 16-year outcome evaluation of the Denbighshire cohort.
    Hobson P; Meara J
    Int J Geriatr Psychiatry; 2015 Oct; 30(10):1048-55. PubMed ID: 25676160
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive and cortical thinning patterns of subjective cognitive decline in patients with and without Parkinson's disease.
    Hong JY; Yun HJ; Sunwoo MK; Ham JH; Lee JM; Sohn YH; Lee PH
    Parkinsonism Relat Disord; 2014 Sep; 20(9):999-1003. PubMed ID: 25001316
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Resting state oscillations suggest a motor component of Parkinson's Impulse Control Disorders.
    Spay C; Meyer G; Lio G; Pezzoli G; Ballanger B; Cilia R; Boulinguez P
    Clin Neurophysiol; 2019 Nov; 130(11):2065-2075. PubMed ID: 31541984
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Default mode network connectivity patterns associated with visual processing at different stages of Parkinson's disease.
    Rektorova I; Krajcovicova L; Marecek R; Novakova M; Mikl M
    J Alzheimers Dis; 2014; 42 Suppl 3():S217-28. PubMed ID: 25114077
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impairment of brain functions in Parkinson's disease reflected by alterations in neural connectivity in EEG studies: A viewpoint.
    Bočková M; Rektor I
    Clin Neurophysiol; 2019 Feb; 130(2):239-247. PubMed ID: 30580247
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Integrative Frequency Power of EEG Correlates with Progression of Mild Cognitive Impairment to Dementia in Parkinson's Disease.
    Gu Y; Chen J; Lu Y; Pan S
    Clin EEG Neurosci; 2016 Apr; 47(2):113-7. PubMed ID: 25519446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Amnestic mild cognitive impairment in Parkinson's disease: a brain perfusion SPECT study.
    Nobili F; Abbruzzese G; Morbelli S; Marchese R; Girtler N; Dessi B; Brugnolo A; Canepa C; Drosos GC; Sambuceti G; Rodriguez G
    Mov Disord; 2009 Feb; 24(3):414-21. PubMed ID: 19235928
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterizing mild cognitive impairment in Parkinson's disease.
    Dalrymple-Alford JC; Livingston L; MacAskill MR; Graham C; Melzer TR; Porter RJ; Watts R; Anderson TJ
    Mov Disord; 2011 Mar; 26(4):629-36. PubMed ID: 21287603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cognitive and Motor Aspects of Parkinson's Disease Associated with Dysphagia.
    Kim JS; Youn J; Suh MK; Kim TE; Chin J; Park S; Cho JW
    Can J Neurol Sci; 2015 Nov; 42(6):395-400. PubMed ID: 26551089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Default-mode network connectivity in cognitively unimpaired patients with Parkinson disease.
    Tessitore A; Esposito F; Vitale C; Santangelo G; Amboni M; Russo A; Corbo D; Cirillo G; Barone P; Tedeschi G
    Neurology; 2012 Dec; 79(23):2226-32. PubMed ID: 23100395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specific patterns of coherence and phase lag index in particular regions as biomarkers of cognitive impairment in Parkinson's disease.
    Zawiślak-Fornagiel K; Ledwoń D; Bugdol M; Romaniszyn-Kania P; Małecki A; Gorzkowska A; Mitas AW
    Parkinsonism Relat Disord; 2023 Jun; 111():105436. PubMed ID: 37167834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration.
    Hanganu A; Bedetti C; Jubault T; Gagnon JF; Mejia-Constain B; Degroot C; Lafontaine AL; Chouinard S; Monchi O
    Mov Disord; 2013 Sep; 28(10):1360-9. PubMed ID: 23801590
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Measuring functional impact of cognitive impairment: validation of the Parkinson's disease cognitive functional rating scale.
    Kulisevsky J; Fernández de Bobadilla R; Pagonabarraga J; Martínez-Horta S; Campolongo A; García-Sánchez C; Pascual-Sedano B; Ribosa-Nogué R; Villa-Bonomo C
    Parkinsonism Relat Disord; 2013 Sep; 19(9):812-7. PubMed ID: 23773412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oscillation-Specific Nodal Differences in Parkinson's Disease Patients with Anxiety.
    Chang B; Mei J; Ni C; Chen P; Jiang Y; Niu C
    J Parkinsons Dis; 2024; 14(4):855-864. PubMed ID: 38701162
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathophysiology of Parkinson's disease behavior--a view from the network.
    Caviness JN
    Parkinsonism Relat Disord; 2014 Jan; 20 Suppl 1():S39-43. PubMed ID: 24262185
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Executive dysfunction in non-demented Parkinson's disease patients with hallucinations.
    Imamura K; Wada-Isoe K; Kitayama M; Nakashima K
    Acta Neurol Scand; 2008 Apr; 117(4):255-9. PubMed ID: 17922890
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of magnetoencephalography (MEG) to study functional brain networks in neurodegenerative disorders.
    Stam CJ
    J Neurol Sci; 2010 Feb; 289(1-2):128-34. PubMed ID: 19729174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive change in Parkinson disease.
    Galvin JE
    Alzheimer Dis Assoc Disord; 2006; 20(4):302-10. PubMed ID: 17132978
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Parkinson's Disease--Cognitive Functional Rating Scale across different conditions and degrees of cognitive impairment.
    Ruzafa-Valiente E; Fernández-Bobadilla R; García-Sánchez C; Pagonabarraga J; Martínez-Horta S; Kulisevsky J
    J Neurol Sci; 2016 Feb; 361():66-71. PubMed ID: 26810519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.